Table:
begin	end	state
1	30	cytoplasmic
31	52	transmembrane
53	57	non-cytoplasmic
58	75	transmembrane
76	111	cytoplasmic
112	134	transmembrane
135	139	non-cytoplasmic
140	161	transmembrane
162	169	cytoplasmic
170	192	transmembrane
193	207	non-cytoplasmic
208	226	transmembrane
227	252	cytoplasmic
253	274	transmembrane
275	299	non-cytoplasmic
300	323	transmembrane
324	351	cytoplasmic
352	373	transmembrane
374	379	non-cytoplasmic
380	402	transmembrane
403	423	cytoplasmic
424	445	transmembrane
446	456	non-cytoplasmic
457	473	transmembrane
474	493	cytoplasmic

Input:
>WP_017178492.1 NCBI__GCF_000295095.1:WP_017178492.1
MTDSTQAGPVAADGEQSEPQELRRSLLSRHLTMISIGGAIGTGLFVASGATISQAGPGGA
LVAYAAVGIMVWLIMQSLGEMAAYLPVAGSFGEYGTRFVSPSFGFAIGWNYWFNWAITVA
AELVAAALVMKYWLPDVPSLVWSALFLVILFTINALSARAYGESEFLFASIKVVAVIVFL
ILGVAMIAGILGGPSPGTENWTTGEAPFVGGGEGILLVLLVAGYSFQGTELIGTAAGEAE
NPERTIPRAIRTIFWRILLFYIGAIAVIGFLIPYTDPNLLNSAEDNVSVSPFTLVFERAG
ILGAASVINAIILTSVLSAGTSGLYSSTRMLFALAERGHAPRFLTRLSSHQVPMNALVAT
TLVGLAGFITSLVGDGAAYEFLLTLSALAGFITWAGISWCHWRFRMALKAQGQPLTDLPY
RARFFPAGAIVALIACIAIIIGQAYGPVTSGKSLGEILMPYIGIPVFLALWWGHKLVTRA
PTVDPATADLERK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server